Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HPGC Medical
Harbin, Heilongjiang, China
- Ownership
- Private
- Employees
- ~2870
- Development stage
- Other
01
Overview
HPGC is a mature pharmaceutical company with commercial products in antibiotics, TCM, and supplements. Recent financial performance shows declining profitability, with net profit attributable to parent company decreasing 35.35% year-on-year in the first three quarters of 2025, though revenue remained relatively stable at 12.021 billion yuan (down 1.92% YoY).
- Therapeutic areas
- HematologyImmunologyOtherCardiovascularInfectious DiseasesPulmonologyGastroenterologyOncology
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Partnerships
GNC Holdings, Inc. (wholly owned as of September 2020)Shanghai Bozhi Research and Development Co., Ltd. (technology transfer for dapoxetine)
Beyond the preview
Go deeper on HPGC Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HPGC Medical.